Exploring the TCGA dataset from cBioPortal (40), we found that breast cancer patients with PTEN low and EphA2 high expression have the worst prognosis among the patients with different levels of PTEN and EphA2 expressions (Fig. 6B). This evidence concerns the gene EPHA2 and breast carcinoma.